IP Library › Granted Patent US 10,646,527
Granted Patent B2
US 10,646,527 · App. 15/887,996 · Granted May 12, 2020

Method of using a

Inventor: Kodimule Shyam Prasad (Bangalore, IN)
Assignee: Vidya Herbs, Inc.
A61K36/22A61K9/0053A61K31/353A61K31/7048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,646,527
App. No.
15/887,996
Granted
May 12, 2020
Kind
B2
Abstract

The invention relates to a herbal composition derived from Mangifera indica . Methods of making and using the composition for the management of obesity are also contemplated.

Claims (23)

1. A method of reducing body fat in a subject in need thereof, comprising administering an effective amount of a composition to said subject, wherein said composition comprises:

about 22% mangiferin,

about 4% catechin,

about 3% epicatechin

about 0.4% quercetin dihydrate,

4.5+/−0.42% gallic acid;

0.93+/−0.23% 3,4 dihydroxy benzoic acid;

1.2+/−0.34% methyl gallate;

2.31+/−0.73% propyl gallate;

0.48+/−0.08% pyrogallol;

1.43+/−0.07% parahydroxy benzoic acid;

0.33+1-0.06% vanillic acid;

0.82+1-0.13% syringic acid;

0.12+1-0.02% ferulic acid;

0.76+1-0.14% ethyl gallate; and

0.16+1-0.05% ellagic acid;

wherein said composition has a total flavonoid content of about 29% and a total polyphenol content of about 19%.

2. The method of claim 1 , wherein the amount effective to reduce body fat in the subject is 500 mg.

3. The method of claim 1 , wherein administering the composition modulates at least one of appetite, body weight gain, metabolism and absorption of calories.

4. The method of claim 1 , wherein administering the composition modulates at least one of insulin levels, lipase levels and lipid peroxidation.

5. The method of claim 1 , wherein administering the composition modulates at least one of serum glucose, total cholesterol, triglyceride, HDL-c and LDL-c levels.

6. The method of claim 1 , wherein administering the composition inhibits super oxide dismutase in the subject.

7. The method of claim 1 , wherein the composition is administered as a powder, pill, tablet, pellet, capsule, thin film, solution, spray, syrup, linctus, lozenge, pastille, chewing gum, paste, vapor, suspension, emulsion, ointment, cream, lotion, liniment, gel, drop, topical patch, buccal patch, bead, gummy, gel, sol or injection.

Continuity (2)
Division 14852604 · Sep 13, 2015
Related Publication 20180256659A1 · Sep 13, 2018
Cited By (1)
US 12,226,443